A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction
- 22 September 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 148 (3) , 518-523
- https://doi.org/10.1016/j.ahj.2004.03.014
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspneaAnnals of Emergency Medicine, 2002
- Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunctionThe American Journal of Medicine, 2001
- Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctionAmerican Heart Journal, 2001
- Efficient utilization of echocardiography for the assessment of left ventricular systolic functionAmerican Heart Journal, 2000
- Screening for Cardiac Dysfunction in Asymptomatic Patients by Measuring B-type Natriuretic Peptide Levels.Japanese Heart Journal, 2000
- Use of echocardiography in the management of congestive heart failure in the communityJournal of the American College of Cardiology, 1999
- Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAmerican Heart Journal, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Recommendations concerning use of echocardiography in hypertension and general population research.Hypertension, 1987